LeMaitre Vascular Inc (LMAT) reports a strong Q3 with 16% sales growth, 49% EPS increase, and strategic market expansion plans.
LeMaitre Vascular Inc (LMAT) reports a strong Q3 with 16% sales growth, 49% EPS increase, and strategic market expansion plans.